Study Summary
This trial aims to study how using Pray.com affects spiritual well-being & mental health in minority groups. Participants will use the app daily & complete surveys to track changes.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 6 Secondary · Reporting Duration: 1 month
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Prayer app
1 of 1
Experimental Treatment
75 Total Participants · 1 Treatment Group
Primary Treatment: Prayer app · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there still opportunities to become a participant in this research endeavor?
"As seen on clinicaltrials.gov, this examination is in the process of seeking participants. This trial was initially advertised on January 24th 2023 and it has been recently updated as of February 1st 2023." - Anonymous Online Contributor
How many participants are accepted into this research endeavor?
"Affirmative. Clinicaltrials.gov's data shows that this clinical trial is currently enrolling participants, with the first post being on January 24th 2023 and latest update on February 1st 2023. The study seeks 75 volunteers from one medical centre." - Anonymous Online Contributor
What objectives is this medical trial seeking to accomplish?
"The primary assessment criteria of this medical trial is user acceptability of a mobile application, and it will be evaluated over the course of one month. Secondary objectives are based on the Multiethnic Identity Measure (Minimum value: 6; Maximum Value: 30), with higher numbers correlating to greater ethnic identity; Perceived Stress Scale (Minimum Value: 0; Maximum Value 40) where increased scores reflect more stress; and Religious Commitment Inventory (Minimum Value 10; Maximum Value 50) which displays a stronger religious commitment as values increase." - Anonymous Online Contributor